River Vision Development Secures $17,000,000 Series A Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=797911b2-4ffa-4a9b-b876-d42f63198ba4&Preview=1 -
Date
12/13/2012 -
Company Name
River Vision Development -
Mailing Address
One Rockefeller Plaza New York, NY 10020 -
Company Description
River Vision Development Corp. was founded by Narrow River Management, LP (Narrow River) for the sole purpose of developing RV001 for GO and other potential indications. The Company is managed under contract with Narrow River, which founds and provides leadership expertise for special purpose drug development companies. -
Website
Undisclosed
-
Transaction Type
Venture Equity -
Transaction Amount
$17,000,000 -
Transaction Round
Series A -
Proceeds Purposes
River Vision Development Corp. today announced the completion of a Series A financing, raising $17 million for the development of a novel protein therapy, RV 001, for the treatment of Graves’ Orbitopathy (GO). -
M&A Terms
-
Venture Investor
SR One -
Venture Investor
Lundbeckfond Ventures -
Venture Investor
Narrow River Management
